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Abstract
Background: Carbonic anhydrases (CAs) are physiologically important enzymes which participate
in many gastrointestinal processes such as acid and bicarbonate secretion and metabolic pathways
including gluconeogenesis and ureagenesis. The genomic data suggests that there are thirteen
enzymatically active members of the mammalian CA isozyme family. In the present study, we
systematically examined the mRNA expression levels of all known CA isozymes by quantitative
real-time PCR in eight tissues of the digestive system of male and female mice.
Results: The CAs expressed in all tissues were Car5b, Car7, and Car15, among which Car5b
showed moderate and Car7 and Car15 extremely low expression levels. Car3, Car12, Car13, and
Car14 were detected in seven out of eight tissues and Car2 and Car4 were expressed in six tissues.
Importantly, Car1, Car3, and Car13 showed very high expression levels in certain tissues as
compared to the other CAs, suggesting that these low activity isozymes may also participate in
physiological processes other than CA catalysis and high expression levels are required to fulfil
their functions in the body.
Conclusion: A comprehensive mRNA expression profile of the 13 enzymatically active CAs in the
murine gastrointestinal tract was produced in the present study. It contributes to a deeper
understanding of the distribution of CA isozymes and their potential roles in the mouse digestive
system.
Background
Mammalian α-carbonic anhydrases (CAs) are a large
enzyme family containing 16 different isoforms, among
which 13 (CA I, II, III, IV, VA, VB, VI, VII, IX, XII, XIII, XIV,
and XV) are enzymatically active. The other three carbonic
anhydrase-related proteins (CA-RP VIII, X, and XI) appear
to lack CA activity because of substitutions in one or more
of the functionally important histidine residues. In addi-
tion, the receptor-type protein-tyrosine phosphatases
(RPTP) β and γ have been reported to contain 'CA-like'
domains [1-3]. The enzymatically active CAs catalyze the
reversible hydration of carbon dioxide in the reaction CO2
+ H2O ⇔ HCO3- + H+, and participate in various biologi-
cal processes, including CO2 transport, regulation of pH
homeostasis, bone resorption, ureagenesis, gluconeogen-
esis, production of body fluids, and fertilization [1,4].
Each isozyme also has a characteristic subcellular localiza-
tion. CA I, II, III, VII, and XIII are cytosolic, CA IV, IX, XII,
XIV, and XV are membrane-associated, CA VA and VB are
mitochondrial, and CA VI is secreted. According to a
recent bioinformatic analysis, CA XV may be the last iso-
form of the mammalian CA gene family to be identified
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opens up a new avenue for studying the expression and
function of all CAs in different tissues.
CAs have been found to be widely expressed along the
entire gastrointestinal canal and in the main digestive
glands where they participate in proton and bicarbonate
secretion, detoxification of ammonia, production of pan-
creatic juice, as well as in absorption of salt and water in
the intestine [6,7]. However, no systematic study has been
conducted to date to describe the comprehensive expres-
sion of all known active CA isozymes in that region. In
order to gain a deeper understanding of the distribution of
CA isozymes and their potential role in the mouse diges-
tive system, we used quantitative real-time PCR to assess
the mRNA expression levels of Car1, Car2, Car3, Car4,
Car5a, Car5b, Car6, Car7, Car9, Car12, Car13, Car14, and
Car15 in the pancreas, liver, oesophagus, stomach, duo-
denum, jejunum, ileum, and colon of male and female
mice.
Results
Expression of transcripts for cytosolic CA isozymes
In this study we investigated the mRNA expression of all
five active cytosolic CA isozymes by quantitative real-time
PCR in the mouse digestive system (Fig. 1). Car1 had a
narrow expression profile and was detected in three out of
eight tissues, with a very high signal in the colon. Lower
expression was also detected in the liver. Differences in
male and female expression levels of Car1 were observed
in the ileum and colon. In the ileum, the expression level
was much higher in female mice than in males, whereas
the opposite was true in the colon, where the expression
level in male mice was almost twice as high as in the
female mice.
Car2 mRNA expression was found in the pancreas, liver,
stomach, duodenum, jejunum, and colon. It was most
intense in the stomach and colon, moderately intense in
the duodenum, and present at lower levels in the pan-
creas, liver, and jejunum. No marked sex differences were
found in the expression levels.
Surprisingly, Car3 had an extremely high expression level
in all tissues except for the duodenum, as compared to the
other CA transcripts. Its expression was highest in the
liver, followed by the oesophagus, colon, and other posi-
tive tissues. Furthermore, its expression level in the liver of
male mice was about twice as high as in females, while no
apparent difference was found in other tissues.
Car7 showed a broad expression pattern, being present in
virtually all of the tissues studied, albeit at a very low level.
Although expression levels in the pancreas differed
between male and female mice, we would expect no sig-
Expression of transcripts for cytosolic CAsFigure 1
Expression of transcripts for cytosolic CAs. Solid and 
open bars represent results obtained from male and female 
mice, respectively.Page 2 of 8
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given the low expression of this transcript.
Car13 was another highly expressed transcript in all tis-
sues except for the liver. Its highest expression was found
in the stomach and jejunum, followed by the oesophagus,
duodenum, ileum, colon, and pancreas. No significant
difference was observed in the expression levels in male
and female mice.
Expression of transcripts for membrane-associated CA 
isozymes
As shown in Figure 2, the expression of different mem-
brane-associated CAs varied dramatically along the ali-
mentary tract. The Car4 expression level increased from
no or a very low signal in the oesophagus and stomach to
a strong one in the colon. The only gender difference was
observed in the duodenum, where the signal was three
times higher in the female mice compared to the males.
Very low Car4 expression was also detected in the pan-
creas. As expected based on a previous study [8], Car9
showed the highest signal in the stomach, and the expres-
sion decreased in the more distal segments of the gastroin-
testinal canal. Car9 expression was below the detection
limit in the liver, pancreas, and oesophagus.
Car14 was most abundant in the liver, moderately
expressed in the oesophagus, and barely detectable in
other tissues. The highest Car12 mRNA levels were
detected in the oesophagus, stomach, ileum, and colon.
In the gut, the expression of Car12 mRNA increased along
the cranial-caudal axis, being most prominent in the
colon. Car15, which has been identified most recently,
was expressed at very low levels in all the tissues studied.
The expression levels were just above the detection limit
of the quantitative PCR.
Expression of transcripts for mitochondrial and secretory 
CA isozymes
The results presented in Fig. 3 indicate that the mitochon-
drial Car5a was found only in the liver, as expected [9],
and no difference was detected between male and female
mice. Car5b, on the other hand, had a wider expression
pattern. It was observed in all tissues examined in the
present study, with the highest signal detected in the
stomach. Car5b expression was low in the pancreas, liver,
oesophagus, ileum, and colon. The tissues showing the
lowest signal were the duodenum and jejunum. Male and
female mice showed quite similar expression levels,
except for the ileum where females showed a markedly
higher signal. Car6 was the only CA transcript which was
negative in all the tissues studied (data not shown).
Expression of transcripts for membrane-associated CAsFigure 2
Expression of transcripts for membrane-associated 
CAs. Solid and open bars represent results obtained from 
male and female mice, respectively.Page 3 of 8
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The expression of individual CA isozymes in mouse tis-
sues has been investigated in several previous studies by
means of RT-PCR, northern blot, and immunohistochem-
ical staining [3,8-12]. Although these studies have signifi-
cantly contributed to our understanding of the
distribution and role of CA isozymes, only one or just a
few isozymes have been examined in each study. The
recent identification of CA XV [5], most probably the last
member of the mammalian CA gene family, has made
possible the parallel examination of all CA isozymes,
which was realized in practise for the first time during the
present investigations. The results obtained clearly con-
firmed that each gastrointestinal organ or segment con-
tains more than one CA isozyme (Fig. 4). A remarkable
finding was also that all CA isozymes except for Car6
showed at least weak mRNA expression in some tissues
studied. In some cases, the expression appeared to be gen-
erally very low as it was with Car7, Car9, Car12, and
Car15. This finding should not, however, diminish the
significance of these isozymes, because even low mRNA
expression can contribute to an important physiological
role. This can be easily realized from the distinct gastric
phenotype which has been reported in CA IX deficient
mice [13].
One surprising finding was that among all cytosolic iso-
zymes, Car3 and Car13 showed the widest expression pro-
files. High levels of Car3 transcript were detected in the
pancreas, liver, oesophagus, stomach, jejunum, ileum,
and colon as compared to the other isozymes. Expression
levels were very high in the liver and oesophagus (the lat-
ter containing substantial amounts of skeletal muscle)
that agrees well with the results obtained in an earlier
study [14]. The wide pattern of Car3 expression was quite
surprising in the context of recent findings showing that
Car3 may be dispensable for mice living in a standard lab-
oratory environment and no gastrointestinal symptoms
were reported in Car3-/- mice [15]. It is conceivable that
Car3 is functionally more important in abnormal condi-
tions such as during oxidative stress [16] or starvation
[17]. Interestingly, the expression level of Car3 transcript
in the liver of male mice was twice as high as in females.
This supports the notion that Car3 is hormonally regu-
lated, as demonstrated in previous studies [18,19]. Simi-
larly to Car3, Car13 was found to be highly expressed in
the digestive tract in comparison with other CAs. Its
mRNA was detected in the pancreas, oesophagus, stom-
ach, duodenum, jejunum, ileum, and colon. The absence
of Car13 in the mouse liver is in good agreement with pre-
vious findings [3]. Although our recent studies have
shown that CA XIII exhibits low catalytic activity [3], the
wide distribution of Car13 at high levels suggests that it
may play an important role in these tissues.
To date, only a few studies have been performed to
explore the expression of CA VII. Its mRNA has been
reported to be abundant in the human salivary gland and
rodent lung and brain, and it was predicted to be widely
distributed, albeit at low levels [20,21]. Indeed, Car7
mRNA expression was observed in all eight tissues in our
study, and the quantification of mRNA indicated very low
signals in all of them. Even though previous studies have
suggested that CA VII represents the most conserved and
ancient form of CAs [22], it is rather difficult to explain
the function of CA VII due to its low catalytic activity and
limited expression pattern.
Analysis of the mRNAs for membrane-associated iso-
zymes revealed high expression levels for Car4 and Car14
in the gut and liver, respectively. The increasing expres-
sion of Car4 towards the distal end of the gastrointestinal
canal is consistent with previous findings in rabbit [23]
and rat [24] and is also in line with the suggestion that CA
IV participates in ion and fluid transport processes taking
place in the distal small and large intestine [24]. A gender
difference in Car4 expression was found in the duode-
num: female mice had three times higher signal level than
males. This finding suggests that Car4 expression might be
directly or indirectly regulated by hormonal factors which
remain to be explored in future studies.
Expression of transcripts for mitochondrial CAsFigure 3
Expression of transcripts for mitochondrial CAs. Solid 
and open bars represent results obtained from male and 
female mice, respectively.Page 4 of 8
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terized and found to be expressed in many species, includ-
ing the mouse. Unlike all other CA isozymes, CA XV is not
expressed in humans and chimpanzees [5]. Its mRNA was
reported to be found in the mouse kidney, brain, testis, 7-
day embryo, and 17-day embryo by conventional RT-
PCR. Our present real-time PCR data showed positive
expression in the liver, stomach, duodenum, jejunum,
ileum, and colon, albeit at extremely low levels.
CA IX has shown a fairly restricted expression profile in
normal mammalian tissues, whereas it is present in sev-
eral human carcinomas [25]. Its expression has been
investigated in the normal human, rat, and mouse gas-
trointestinal tracts [8,26,27]. In this study, Car9 showed
the highest expression in the stomach, and the signal
intensity decreased along with the cranial-caudal axis of
the lower gastrointestinal canal, being barely detectable in
the colon. Interestingly, in our previous study the expres-
sion of Car9 in the stomach of Car2-/- mice compared to
wild type mice was twice as high at the mRNA level and
three times as high at the protein level, which may reflect
compensatory upregulation of Car9 in response to the
loss of the high activity of Car2 [12].
The second isozyme associated with cancer, CA XII, has
been found mainly in the kidney and colon, while trace
expression of its mRNA has also been detected in the rab-
bit duodenum, jejunum, and ileum [10,23,28]. Our data
confirm these findings in the duodenum, jejunum, ileum,
and colon. Surprisingly, Car12 mRNA was observed in the
oesophagus and stomach at a comparable level to the
colon, and trace expression was also found in the pan-
creas. Notably, the signals for Car12 were generally very
low in all gastrointestinal tissues. This finding agrees well
with our recent results which showed low expression in
the stomach and colon and markedly higher signals in the
kidney [12].
CA VA and CA VB are distinct isoforms in that they are
localized to the mitochondrial matrix. CA VA expression
is abundant in the liver, while CA VB is more widely dis-
tributed, being present in almost all tissues [9,29]. The
same kind of expression pattern was observed in the
present study: Car5a transcript was detectable only in the
liver, whereas Car5b was present in all eight tissues stud-
ied. The differences in the distribution might reflect differ-
ent physiological roles or efficacy for CA VA and VB in
metabolic pathways requiring mitochondrial bicarbonate
production.
Conclusion
The present study provides the first comprehensive mRNA
expression profile of the 13 enzymatically active CAs in
the mouse digestive system. The present evidence that
mRNAs for all CA isozymes except for CA VI are expressed
in the gastrointestinal tissues clearly indicates the com-
plexity of the physiological processes in this region. In
addition, CA isozymes are known to be differentially
expressed not only along the intestinal segments but also
between different cell types within a particular organ.
Finally, it is a matter of debate whether the regulatory
mechanisms could be different depending on the gender
and species. Even though some of these isozymes have
heretofore been demonstrated only in rodents, it is con-
ceivable that general transport and pH regulation mecha-
nisms are qualitatively quite similar in various species
[30,31]. Nonetheless, the described complex distribution
of various Car mRNAs emphasizes the need for functional
studies where certain CA isozymes are selectively targeted
one at a time. To date only single and double knockout
studies have been performed on CA isozymes
[13,15,32,33], and making triple knockouts would be
A schematic model showing relative mRNA expression levels of diff rent CA isozymes in the gastrointestinal tractFigure 4
A schematic model showing relative mRNA expres-
sion levels of different CA isozymes in the gastroin-
testinal tract. Only the Car transcripts with moderate 
(relative expression value 10–100) or high expression (rela-
tive expression value >100) levels are included in the model.Page 5 of 8
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available, would potentially offer novel tools to study
these phenomena. On the other hand, these inhibitors
provide only partial explanations in that while they
inhibit CA enzymatic activity all other functions can
remain unaffected. Based on these facts, it will still be
challenging to completely understand the role of each CA
isozyme, although the major pieces in this puzzle have
now been identified in the gastrointestinal tract organs.
Methods
RNA extraction and first strand cDNA synthesis
The tissue samples used for mRNA quantification were
obtained from 10-week-old NMRI mice (four males and
four females) with the approval of the Animal Care Com-
mittee of the University of Tampere. The tissues extracted
included the pancreas, liver, oesophagus, stomach, duo-
denum, jejunum, ileum, and colon. All specimens used
for quantitative real-time PCR were snap frozen upon
extraction and stored at -80°C until use. Total RNA was
isolated from tissue samples using TRIZOL reagent (Invit-
rogen, Carlsbad, CA) following the manufacturer's
instructions. After digestion of potential residual DNA
with RNase-free DNase I (Novagen, Madison, USA), the
resulting RNA samples were further purified with phenol/
chloroform followed by precipitation with ice-cold etha-
nol. RNA concentration and purity was determined by
optical density measurement at 260 and 280 nm. RNAs
extracted from males and females were separately pooled
to reduce the potential for individual variation. 3 μg of
total RNA was converted into first strand cDNA using the
First Strand cDNA Synthesis kit (Fermentas, Burlington,
Canada) and random hexamer primers according to the
protocol recommended by the manufacturer.
Quantitative real-time PCR
The amount of mouse Car1, Car2, Car3, Car4, Car5a,
Car5b, Car6, Car7, Car9, Car12, Car13, Car14, and Car15
transcripts in different tissues was assessed by quantitative
real-time PCR using the Lightcycler detection system
(Roche, Rotkreuz, Switzerland). Real-time PCR primers
were designed on the basis of the complete cDNA
sequences deposited in GenBank (accession numbers:
NM_009799 for Car1, NM_009801 for Car2,
NM_007606 for Car3, NM_007607 for Car4,
NM_007608 for Car5a, NM_019513 for Car5b,
NM_009802 for Car6, NM_053070 for Car7,
NM_139305 for Car9, NM_178396 for Car12,
NM_024495 for Car13, NM_011797 for Car14, and
NM_030558 for Car15). To avoid amplification of con-
taminating genomic DNA, two primers from each primer
set were placed in different exons. GAPDH (glyseralde-
hyde-3-phosphate dehydrogenase), HPRT1 (hypoxan-
thine phosphoribosyltransferase 1), and SDHA (succinate
dehydrogenase complex, subunit A, flavoprotein (Fp))
were used as internal RNA controls to normalize the RNA
samples for differences. HPRT1 primer sequences are
available in the public QPPD database [34] with identifi-
cation number 10050 and the primer sequences for SDHA
were obtained from the public PrimerBank database [35]
with the identification number 15030102a2. GAPDH
primers were designed on the basis of the complete
GAPDH cDNA sequences (accession numbers:
NM_001001303). Table 1 shows the primer sequences
used for GAPDH and the 13 CAs.
Every PCR was performed in a total reaction volume of 20
μl containing 0.5 μl of first strand cDNA, 1× of QuantiTect
SYBR Green PCR Master Mix (Qiagen, Hilden, Germany),
and 0.5 μM of each primer. Amplification and detection
were carried out as follows. After an initial 15-min activa-
tion step at 95°C, amplification was performed in a three-
Table 1: Primer sequences for quantitative real-time PCR
Gene Forward primer (5'-3') Reverse primer (5'-3') PCR product size (bp) Tm (°C)
GAPDH ATGGTGAAGGTCGGTGTG CATTCTCGGCCTTGACTG 186 56
Car1 TTGATGACAGTAGCAACC CCAGTGAACTAAGTGAAG 161 51
Car2 CAAGCACAACGGACCAGA ATGAGCAGAGGCTGTAGG 122 56
Car3 GCTCTGCTAAGACCATCC ATTGGCGAAGTCGGTAGG 160 54
Car4 CTCCTTCTTGCTCTGCTG GACTGCTGATTCTCCTTA 145 55
Car5a ACCAAAGCAAGGGCATACAG TGGCACAGAGAAGTCCCACA 104 58
Car5b AATGGCTTGGCTGTGATAGG GGCGTAGTGAGAGACCCAGA 187 60
Car6 AAGATTGACGAGTATGCC TAGGTGTAATAGTGGTGG 145 54
Car7 CAATGACAGTGATGACAGAA TCCAGTGAACCAGATGTAG 160 55
Car9 CTGAAGACAGGATGGAGAAG GCAGAGTGCGGCAGAATG 221 57
Car12 CCTATGTTGGTCCTGCTG CGTTGTAACCTTGGAACTG 143 53
Car13 AATACGACTCCTCACTCC TGCCGCAACCTGTAGTTC 116 52
Car14 TGTTGTTCTTCGCTCTCCTG CACTGTCTGTCTGGATATTG 161 53
Car15 AGCACAGCCTGGATGAGA CAGACACAATGGCAGAGA 170 55
Tm: annealing temperaturePage 6 of 8
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rate 20°C/s; annealing at Tm, 20s, ramp rate 20°C/s; and
elongation at 72°C, 20s, ramp rate 20°C/s for 45 cycles,
and final cooling step. The melting curve analysis was
always performed after the amplification to check PCR
specificity. To quantify the concentration of reference
genes and the 13 Car transcripts in the eight tissues of this
study, a standard curve for each gene was established
using five-fold serial dilutions of known concentrations of
purified PCR products generated from the same primer
sets. Each cDNA sample was tested in duplicate, and the
crossing point (Cp) value obtained allowed us to deter-
mine the amount of the starting message using the specific
standard curve. The geometric mean of the three reference
genes was used as an accurate normalization factor for
gene expression levels [36]. The final relative mRNA
expression was indicated as the copy number of target
gene in each tissue divided by the corresponding normal-
ization factor and subsequently multiplied by 103. The
mean coefficient of variation in Car mRNA levels calcu-
lated from duplicate samples was 6.965%.
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